Ultragenyx Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
NOVATO, Calif., June 12, 2024 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development […]
NOVATO, Calif., June 12, 2024 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development […]
As Former Chief Concept Officer at Panera Bread, Davis led culinary development, category management, restaurant design, and sustainability efforts. At […]
SOUTH SAN FRANCISCO, Calif., June 12, 2024 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX), today announced that on June […]
Venlo, the Netherlands, June 12, 2024 (GLOBE NEWSWIRE) — QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today released its 2023 […]
VENLO, Niederlande, June 12, 2024 (GLOBE NEWSWIRE) — QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) hat heute seinen Nachhaltigkeitsbericht 2023 veröffentlicht, […]
ALBUQUERQUE, N.M., June 12, 2024 (GLOBE NEWSWIRE) — Today, Kevin G. Hostetler, chief executive officer of Array Technologies (NASDAQ: ARRY), […]
BOSTON and SAN DIEGO, June 12, 2024 (GLOBE NEWSWIRE) — Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company focused […]
The development of VTP-300 in chronic Hepatitis B (CHB) and VTP-1000 in celiac disease will be prioritized. The pipeline prioritization […]
– Oral difelikefalin did not demonstrate meaningful clinical benefit compared to placebo – – Company will discontinue clinical program in […]
Catcha Shareholders Approved the Previously Announced Business Combination at the Extraordinary General Meeting held June 12, 2024 Crown and Catcha […]